Navigantis is growing a surgical robotic for a variety of neurovascular indications, together with acute ischemic stroke. | Supply: Navigantis
Navigantis Inc. final week introduced the primary profitable scientific procedures carried out with its Vasco surgical robotic for sufferers affected by neurovascular issues. The interventional circumstances concerned sufferers present process diagnostic cerebral angiogram, mind tumor embolization, and mechanical thrombectomy for ischemic stroke.
“This achievement marks an vital milestone in our mission to introduce the benefits of robotic procedures to the interventional neurovascular subject,” acknowledged Mor Dayan, CEO of Navigantis.
“The Vasco robotic platform has the potential to redefine how we strategy probably the most complicated and time-sensitive neurovascular procedures, finally enhancing each affected person outcomes and procedural efficiencies,” he added. “This is likely one of the first steps in the direction of enabling robotic telesurgery for stroke sufferers, which might dramatically cut back response instances and improve entry to well timed vital care.”
Neurovascular illnesses require well timed remedy
Neurovascular illnesses, together with stroke, aneurysms, and arteriovenous malformations (AVMs) are main causes of dying and incapacity worldwide, in keeping with Navigantis. Strokes have an effect on somebody within the U.S. each 40 seconds, and they’re the main explanation for incapacity.
Mechanical thrombectomy (MT) is now the “gold customary” for acute ischemic stroke, famous the Miami-based firm. If a affected person receives MT inside two hours from the onset of signs, she or he has a 90% probability of re-achieving independence. At six hours, the quantity drops to 30%.
Navigantis asserted that these numbers reaffirm the significance of guaranteeing that procedures are well timed and broadly out there. They’re at the moment constrained by the inadequate variety of skilled neuro-interventionalists and the restricted entry outdoors city areas.
Regardless of enhancements in stroke programs of care, many Individuals nonetheless lack well timed entry to acute stroke intervention, Navigantis stated.
Register immediately to avoid wasting 40% on convention passes!
Navigantis takes steps to extra complicated surgical procedure
Based in 2022, Navigantis has developed an interventional robotic platform for a variety of neurovascular procedures and indications, together with acute ischemic stroke. VASCO is an investigational machine and is at the moment present process scientific analysis outdoors the U.S. It isn’t accredited for industrial use in any jurisdiction, together with the U.S.
As extra endovascular procedures requiring fluoroscopy for imaging steerage are carried out to deal with neurovascular illnesses, it has develop into vitally vital to deal with reducing radiation publicity. The applying of robotics for interventional procedures will significantly cut back it, Navigantis stated.
Prof. Dong Joon Kim, a pioneer within the robotic neuro-interventional house and the chairman of radiology at Severance Hospital in Seoul, South Korea, led the examine.
“These first profitable robotic circumstances are a serious stepping stone in the direction of treating extra complicated neurovascular illnesses,” stated Prof. Kim.
The corporate stated this achievement builds on its earlier first-in-human (FIH) trials in 2022, through which physicians used the earlier technology of VASCO to efficiently carry out robotic embolization of liver tumors.
In July 2024, Navigantis closed a $12 million Sequence A funding spherical. The corporate stated proceeds from the financing shall be used to assist the continuing improvement and testing of the robotic to carry VASCO to FIH scientific trials for neurovascular procedures.
The Navigantis staff on the Society of Robotic Surgical procedure. From left to proper: Hyosig Kang, the co-founder and CTO; Mor Dayan, co-founder and CEO; and Marc Camprubí Artal, head of operations. | Supply: Navigantis by way of LinkedIn
